Organogenesis Holding (ORGO) Reports In-Line Q4 EPS

Organogenesis Holding (NASDAQ: ORGO) reported Q4 EPS of $0.06, in-line with the analyst estimate of $0.06. Revenue for the quarter came in at $115.5 million versus the consensus estimate of $122.05 million.

For earnings history and earnings-related data on Organogenesis Holding (ORGO) click here.

You May Also Be Interested In

• General Aerospace (GE) Tops Q2 EPS by 16c, Beats on Revenue; Offers FY26 EPS Guidance
• Tanzanian Royalty Exploration (TRX) Misses Q3 EPS by 3c
• IBM (IBM) PT Lowered to $280 at Argus